Since the selenoenzyme GPX4 is a critical component of the antioxidant machinery in TNBC cells, the possible involvement of SLC38A5 in the delivery of selenium into cancer cells in the form of Se-Met could represent a novel function of the transporter in promoting cancer growth. Here, GPX4 is linked to cancer.